Based on its marked overexpression in multiple malignancies and its roles in promoting cell survival and proliferation, survivin is an attractive candidate for targeted therapy. Towards this end, a detailed understanding of the mechanisms regulating survivin expression in different cancer cells will be critical. We have previously shown that the RNA-binding protein (RBP) CUG-BP1 is overexpressed in esophageal cancer cells and post-transcriptionally regulates survivin in these cells. The objective of this study was to investigate the role of microRNAs (miRs) in regulating survivin expression in esophageal cancer cells. Using miR expression profiling analysis, we found that miR-214-3p is one of the most markedly downregulated miRs in two esophageal squamous cancer cell lines compared to esophageal epithelial cells. Interestingly, using miR target prediction programs, both survivin and CUG-BP1 mRNA were found to contain potential binding sites for miR-214-3p. Forced expression of miR-214-3p in esophageal cancer cells leads to a decrease in the mRNA and protein levels of both survivin and CUG-BP1. This effect is due to decreased mRNA stability of both targets. By contrast, silencing miR-214-3p in esophageal epithelial cells leads to an increase in both survivin and CUG-BP1 mRNA and protein. To determine whether the observed effect of miR-214-3p on survivin expression was direct, mediated through CUG-BP1, or both, binding studies utilizing biotin pull-down assays and heterologous luciferase reporter constructs were performed. These demonstrated that the mRNA of survivin and CUG-BP1 each contain two functional miR-214-3p binding sites as confirmed by mutational analysis. Finally, forced expression of miR-214-3p enhances the sensitivity of esophageal cancer cells to Cisplatininduced apoptosis. This effect is abrogated with rescue expression of survivin or CUG-BP1. These Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms 
Introduction
Resistance to chemotherapy-induced apoptosis is a crucial mechanism for tumor cell survival [ 1 ] . Survivin, a member of the Inhibitor of Apoptosis Protein (IAP) family, has been shown to be overexpressed in multiple malignancies, including esophageal cancer [ 2 , 3 ] . In esophageal cancer cell lines, downregulation of survivin significantly enhances the sensitivity of these cells to chemotherapy-induced apoptosis [ 4 ] . Furthermore, failure to downregulate survivin following neo-adjuvant chemoradiotherapy has been correlated with decreased survival in esophageal cancer patients [ 5 ] . Coupled with the fact that it is not expressed in most normal tissues, survivin is an enticing candidate for targeted therapy in esophageal cancer.
A thorough understanding of the mechanisms regulating survivin overexpression in esophageal cancer cells will be essential for optimizing therapeutic strategies. Posttranscriptional regulatory processes mediated by trans-acting factors such as RBPs, miRs, and long non-coding RNAs, play important roles in the control of gene expression in cancer cells [ 6 -8 ] . These factors interact with multiple gene products, some of which may be involved in coordinated networks [ 9 ] . Identifying important regulators of survivin may reveal crucial nodal agents that modulate the expression of multiple targets involved in esophageal carcinogenesis.
We have previously shown that the RBP CUG-BP1 plays an important role in regulating the overexpression of survivin in esophageal cancer cells by stabilizing its mRNA [ 10 ] . Although additional data on the relationship between other RBPs and survivin is scarce, several reports exist regarding the regulation of survivin by various miRs, although none exist in esophageal cancer cells. miR-34a has been shown to be downregulated in both gastric cancer and laryngeal squamous cell cancer [ 11 -12 ] . Overexpression of miR-34a in these cell lines resulted in decreased survivin expression, which led to decreased proliferation and increased apoptosis. Expression of miR-203 has been shown to be markedly attenuated in prostate, pancreas, and hepatocellular cancer (HCC) cell lines [ 13 -15 ] . Ectopic expression of miR-203 in these cells leads to decreased survivin expression with an associated reduction in cellular proliferation and enhancement in sensitivity to chemotherapy-induced apoptosis. Given the cell type-specific nature of the interaction between survivin and miRs, the goal of this study was to assess global miR expression in two esophageal squamous cancer cell lines compared to esophageal epithelial cells. miR target prediction models were employed to determine whether any of the most markedly downregulated miRs could interact with survivin mRNA. Functional, binding, and phenotypic assays were performed to characterize this interaction.
Results

miR-214-3p expression is markedly decreased in esophageal cancer cell lines
Global miR expression in human esophageal epithelial (hESO) cells and the human esophageal squamous cell cancer lines TE7 and TE10 was determined by array analysis using the 7th generation miR Array (Exiqon, Denmark). Expression levels of approximately 2,000 distinct human miRs were examined. Four hundred twenty-four miRs were found to be differentially expressed above the threshold level and formed the basis for the subsequent analysis. When the 30 miRs with the greatest magnitude of differential expression between the cancer cells and epithelial cells were analyzed, 18 were found to share similar expression patterns in both TE7 and TE10 cells. A heat map depicting the two-way hierarchical clustering analysis of these 18 miRs is depicted in Figure 1A . In Table 1 , these 18 miRs are grouped into the 11 whose expression is most markedly downregulated in the cancer cells lines (a) and the 7 whose expression is most upregulated compared to the hESO cells (b) .
Based on bioinformatics analysis, mir-214-3p is predicted to bind with strong affinity to both survivin and CUG-BP1 mRNA. As seen in Table 1a , miR-214-3p is dramatically downregulated in both TE7 and TE 10 cells compared to hESO cells, with a log fold change of approximately −3 in each cell line. In order to confirm these findings, total RNA was harvested from all three cell lines and real-time PCR (q-PCR) analysis was performed to measure miR-214-3p levels. As seen in Figure 1B , these results confirm that miR-214-3p levels are significantly decreased in TE7 and TE10 cells compared to hESO cells.
Modulating miR-214-3p levels leads to alterations in both survivin and CUG-BP1 protein expression
Because basal levels of miR-214-3p are low in TE7 and TE10 cells, transfection of premiR-214-3p into these cells was performed in order to assess the effects on survivin and CUGBP1 protein expression. In reciprocal experiments, anti-miR-214-3p was employed to reduce miR-214-3p levels in hESO cells. As shown in Figure 2A , transfection efficiency of pre-miR-214-3p was robust in both TE7 and TE10 cells (a). Similarly, transfection of antimiR-214-3p was very effective in reducing miR-214-3p levels in hESO cells (b) . Following successful transfection of pre-miR-214-3p, both survivin and CUG-BP1 protein levels are markedly decreased in TE7 and TE10 cells ( Figure 2B a,b) . Of note, there was no effect on protein levels of the RBP HuR, which has also been shown to regulate survivin expression [ 16 ] . Conversely, both survivin and CUG-BP1 protein levels were increased in hESO cells following transfection of anti-miR-214-3p ( Figure 2B c) . There was no change in HuR expression following silencing of miR-214-3p in hESO cells.
miR-214-3p reduces both survivin and CUG-BP1 mRNA stability
To further investigate the mechanism by which miR-214-3p affects survivin and CUGBP1 protein expression, levels of survivin and CUG-BP1 mRNA were assessed following overexpression of pre-miR-214-3p in TE7 and TE10 cells, as well as following transfection of anti-miR-214-3p in hESO cells. As seen in Figure 3A , transfection of pre-miR-214-3p was associated with a decrease in both survivin and CUG-BP1 mRNA levels in both TE7 and TE10 cells. In hESO cells, reduction of miR-214-3p expression led to an increase in both survivin and CUG-BP1 mRNA levels ( Figure 3B ). Figure 3C depicts stability of both survivin and CUG-BP1 mRNA following transfection of pre-miR-214-3p in TE7 cells. In these experiments, 24 hours following transfection, cells are exposed to 0.2 μM of Actinomycin D to prevent further transcription. Total cellular RNA is harvested at specified time points and levels of target mRNA are measured by q-PCR. As seen in these curves, both survivin and CUG-BP1 mRNAs are destabilized following premiR-214-3p transfection. The stability curves in Figure 3D demonstrate enhanced stability of both survivin and CUG-BP1 mRNA following silencing of miR-214-3p in hESO cells. miR 214-3p binds to both survivin and CUG-BP1 mRNA
As it was not clear whether the observed effect of miR-214-3p on survivin mRNA and protein expression resulted from a direct interaction with survivin mRNA, indirectly through an interaction with CUG-BP1 mRNA, or both, we next sought to determine whether miR-214-3p bound to both survivin and CUG-BP1 mRNA. As seen in Figure 4A , there are 3 predicted miR-214-3p binding sites in the 3' untranslated region (UTR) of survivin mRNA. For CUG-BP1 mRNA, there are 5 predicted binding sites for miR-214-3p. Two are located in the coding region (CR) and 3 are found in the 3' UTR. As a first step in the binding analysis, following transfection of biotin-labeled miR-214-3p into TE7 cells, cell lysates were exposed to avidin-coated beads. RNA was harvested from the pull-down material and amplified with survivin, CUG-BP1 and HuR probes by q-PCR. A biotin-labelled scrambled miR served as a control in these experiments. The levels of survivin mRNA and CUG-BP1 mRNA were markedly elevated in the pull-down material isolated from TE7 cells following transfection with biotin-labeled miR-214-3p compared to control ( Figure 4B ). There was no difference in the levels of HuR mRNA.
In order to determine which potential binding sites in survivin mRNA were being utilized for binding with miR-214-3p, 5 fragments were PCR amplified and separately sub-cloned into luciferase reporter vectors ( Figure 5A ). One fragment (FL 3'UTR) contained the entire full-length 3'UTR. Fragment 1 encompassed the CR, which does not contain a binding site, while the remaining 3 fragments of the 3'UTR each contained an individual binding site. Following co-transfection with pre-miR-214-3p or control miR, there was an approximately 50% reduction in luciferase activity with FL 3' UTR. Co-transfection with either Fragment 2 or 4 with premiR-214-3p resulted in an approximately 25% decrease in luciferase activity. There was no decrement in luciferase activity following transfection with either Fragment 1 containing the CR or Fragment 3 in the 3' UTR ( Figure 5B ). Following mutation of 4 bases in the seed sequence binding region of the predicted miR-214-3p binding sites in Fragment 2 ( Figure 5C ) and Fragment 4 ( Figure 5D ), no decrement in luciferase activity was observed following cotransfection with either mutated fragment and pre-miR-214-3p. Finally, mutating both binding sites in FL 3'UTR resulted in complete abrogation of the 50% decrement in luciferase activity seen with the wild type full-length construct ( Figure 5E ).
A similar set of experiments was performed to analyze the relative contributions of the 5 predicted binding sites for miR-214-3p in CUG-BP1 mRNA. Five fragments of CUG-BP1 mRNA, each containing a unique potential binding site, were PCR amplified ( Figure 6A ). Fragments 1 and 2 contained binding sites located within the CR, while Fragments 3-5 contained binding sites located in the 3' UTR. Each fragment was then separately subcloned into a luciferase reporter vector. Following co-transfection of pre-miR-214-3p or control miR with each construct, luciferase activity was measured. As seen in Figure 6B luciferase activity was decreased by approximately 50% following transfection with the construct containing the binding site in Fragment 1 in the CR and by approximately 40% following transfection with the construct containing the binding site in Fragment 4 in the 3' UTR. There were no significant changes in luciferase activity following transfection with the constructs containing the other 3 potential binding sites. Finally, site directed mutagenesis was performed to alter 3 bases in the seed sequence binding region of the predicted miR-214-3p binding sites in Fragment 1 and Fragment 4. These mutated fragments were then cloned into luciferase reporter vectors. As seen in Figures 6C and 6D , co-transfection of the mutated constructs and pre-miR-214-3p abrogated the decrement in luciferase activity seen with the wild-type constructs.
Overexpression of miR 214-3p enhances susceptibility of TE7 cells to Cisplatin-induced apoptosis
Based on our previous findings that silencing either survivin or CUG-BP1 enhanced the sensitivity of TE7 cells to chemotherapy-induced apoptosis, we predicted similar results following forced expression of miR-214-3p in these cells. In the time course experiment depicted in Figure 7A , TE7 cells were transfected with pre-miR-214-3p or control miR for 48 hours. At that time, cells were exposed to 15 μM Cisplatin and cell lysates harvested at various time points. Western blot analysis of lysates harvested 24 hours following Cisplatin exposure revealed a marked increase in caspase-3 protein levels in cells transfected with premiR-214-3p compared to control. In order to determine whether the observed enhancement in apoptosis following overexpression of miR-214-3p was due to its reduction in survivin and/or CUG-BP1 levels, rescue experiments were performed. As seen in Figure 7B , overexpression of either survivin or CUG-BP1 following transfection of miR-214-3p restores expression of these proteins. Following restoration of either survivin or CUG-BP1 expression, TE7 cells exposed to Cisplatin following transfection with pre-miR-214-3p no longer demonstrate release of caspase-3 ( Figure 7C ).
To ensure that the observed caspase-3 seen following miR-214-3p overexpression was functional, a caspase-3 ELISA assay was performed under the same conditions. This revealed a two-fold increase in caspse-3 enzyme activity following 24 hours of exposure to Cisplatin in TE7 cells transfected with pre-miR-214-3p relative to control ( Figure 7D ). To further confirm this increased sensitivity to Cisplatin-induced apoptosis, TE7 cells underwent flow cytometry analysis for Annexin-V expression. Treatment with premiR-214-3p alone or control miR plus Cisplatin resulted in approximately 5-10% of cells staining positive for Annexin-V expression, whereas over 50% of TE7 cells transfected with pre-miR-214-3p and exposed to Cisplatin stained positive for Annexin-5 (Figures 7E and 7F).
Phatak et al.
Page 5 Oncogene. Author manuscript; available in PMC 2016 May 18.
Discussion
Our findings indicate that miR-214-3p is markedly downregulated in esophageal squamous cancer cell lines compared to esophageal epithelial cells. We also demonstrate that miR-214-3p regulates survivin expression in these esophageal cancer cells, by both a direct interaction with survivin mRNA, as well as indirectly through an interaction with CUG-BP1 mRNA. Forced expression of miR-214-3p in esophageal cancer cells leads to a decrease in both mRNA and protein levels of survivin and CUG-BP1, associated with decreased mRNA stability of both targets. Finally, overexpression of miR-214-3p results in markedly enhanced sensitivity of esophageal cancer cells to Cisplatin, which is abrogated following rescue expression of either survivin or CUG-BP1.
The analysis of global miR expression in both TE7 and TE10 cells compared to hESO cells is in agreement with a study from Matsushima and colleagues who compared miR expression between the esophageal squamous cancer cell lines TE10 and OE-21 and the immortalized esophageal epithelial line Het-1A [ 17 ] . All five of the miRs (miRs-141, 200c, 203, 205, 429) found to be most upregulated in their study were also upregulated by at least 2 log-fold in both cancer cell lines in our analysis. Seven of the nine miRs (miRs-10a, 99a, 100-5p, 125b, 146b, 376a, 379) found to be most downregulated in the cancer cell lines were also downregulated by 1 to 2 log-fold in the TE7 and TE10 cell lines used in our study. The relative expression of miR-214-3p was not detailed in their report. However, in a study comparing miR expression in 40 esophageal squamous cell cancer specimens and matched normal tissues, miR-214-3p was found to be significantly downregulated in 77.5% of samples [ 18 ] .
The data presented here not only demonstrate a new role for miR-214-3p as an important post-transcriptional regulator of survivin in esophageal squamous cancer cells, but, by also describing its interaction with CUG-BP1, enhance the understanding of the complex regulatory relationships that exist between miRs and RBPs [ 19 ] . In the only other study describing post-transcriptional regulation of CUG-BP1, miR-503 was shown to negatively influence the translational efficiency of CUG-BP1 mRNA in intestinal epithelial cells [ 20 ] .
In that report, similar to our results with miR-214-3p, altering expression of miR-503 profoundly affected the anti-apoptotic effect promoted by CUG-BP1. Silencing miR-503 resulted in increased levels of CUG-BP1, which protected cells from TNFα -induced apoptosis. Intriguingly, the upregulated targets of CUG-BP1 responsible for this phenomenon, c-IAP1 and c-IAP2, are members of the same IAP family as survivin. Furthermore, simultaneous silencing of miR-503 and CUG-BP1 abolished this increase in c-IAP1 and c-IAP2 levels, providing additional evidence that CUG-BP1 enhances the expression of these anti-apoptotic proteins.
Our findings indicate that the pro-apoptotic effect observed following forced expression of miR-214-3p, is related at least in part, to the reduction in survivin expression. It is certainly possible, however, that additional targets of both miR-214-3p and CUG-BP1 may also be reduced. Alterations in levels of both miR-214-3p and CUG-BP1 have been shown to affect sensitivity to chemotherapy-induced apoptosis in cancer cells, although their expression and targets vary considerably across different malignancies. In ovarian cancer cells, where miR-214-3p is overexpressed compared to normal tissues, miR-214-3p was shown to downregulate PTEN [ 21 ] . PTEN downregulation led to activation of the Akt pathway, thereby promoting cell survival and resistance to Cisplatin. Similarly, in nasopharyngeal cancer, the upregulation of miR-214-3p led to decreased levels of the pro-apoptotic protein Bim [ 22 ] . Conversely, miR-214-3p has been shown to be downregulated relative to normal cells in HCC and cervical cancer. In each case, miR-214-3p was found to target an antiapoptotic gene; XBP-1 in HCC and Bcl2l2 in cervical cancer, such that the loss of miR-214-3p in these cells resulted in the increased expression of its anti-apoptotic targets [ 23 -24 ] . Additionally, forced expression of miR-214-3p in the esophageal squamous cancer cell line Eca109 inhibited expression of the enhancer of zeste homolog 2 (EZH2) [ 18 ] . Of note, EZH2 was also found to be a target of miR-214-3p in HCC [ 25 ] . In both reports, overexpression of miR-214-3p led to decreased proliferation and invasion capacity of the transfected cancer cells.
In addition to our previous description of its role in regulating survivin expression in esophageal cancer cells, other evidence supports an important role for CUG-BP1 in promoting an anti-apoptotic phenotype in cancer cells. CUG-BP1 has been shown to be overexpressed in both oral squamous cancer cell lines and human tumors [ 26 ] . In these cells, CUG-BP1 bound to the 3'UTRs of the mRNAs encoding the pro-apoptotic proteins BAD and BAX, and facilitated their degradation. Silencing CUG-BP1 therefore resulted in increased levels of BAD and BAX and enhanced sensitivity to chemotherapy-induced apoptosis. Gareau and colleagues described the ability of CUG-BP1 to mediate resistance to the proteasome inhibitor bortezomid in HeLa cells by stabilizing p21 mRNA [ 27 ] . Together with our findings, these data regarding targets of miR-214-3p and CUG-BP1 in cancer cells raise the intriguing possibility that miR-214-3p and/or CUG-BP1 could serve as important regulators of multiple anti-apoptotic effectors in esophageal cancer cells. This suggests a model in which loss of these post-transcriptional regulators could be important events in esophageal carcinogenesis.
Materials and Methods
Cell culture and reagents
The human esophageal squamous cancer cell lines TE7 and TE10 are kind gifts from Dr. Nishihira (Tohoku University, Sendai Japan). These cell lines were cultured in RPMI media (Mediatech Inc, Herndon, VA) supplemented with 10% heat-inactivated FBS. hESO is a spontaneously immortalized esophageal epithelial cell line derived from esophageal specimens harvested at the time of donor lung procurement. These cells were cultured in BEBM media (Lonza Corp, Walkersville, MD) supplemented with 20% heat-inactivated FBS and the BEGM bullet kit. All cells were maintained in a 37°C incubator with 5% CO2 humidified air.
Transfection
Cells were seeded in 6 cm plates at a density of 0.5-1 × 10 6 , a day prior to transfection. For miR transfections, pre-miR-214-3p (12 nM), anti-miR-214-3p (25 nM), or control miR (Ambion, Austin, TX) was diluted in 500μl Opti-MEM I (Invitrogen, Carlsbad, CA) containing 5 μl Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA). After 15 min incubation at room temperature (RT), the complex was added to the cells in a final volume of 5 ml of fresh medium. In order to transiently over-express CUG-BP1 and survivin, TE7 cells were transfected with 2 μg of pCMV6-XL5 plasmid containing CUG-BP1 or survivin cDNA (OriGene, Rockville, MD) diluted in 500μl Opti-MEM I containing 5 μl Lipofectamine 2000 (Invitrogen, Carlsbad, CA).
Global miRNA expression Profiling
hESO, TE7 and TE10 cells (two replicates each) were seeded in 6 cm plates at passage 5. Total RNA was isolated using miRNeasy Mini Kit (Qiagen, Valencia, CA) according to manufacturer's manual. All the experiments for miR array were conducted at Exiqon Services, Denmark. Briefly, RNA quality was verified by an Agilent 2100 Bioanalyzer profile. Total RNA (750 ng) of each sample and common reference was labeled with Hy3 and Hy5 fluorescent label using the miRCURY LNA microRNA Hi-Power labeling kit (Exiqon). RNA samples were mixed pairwise and hybridized to the miRCURY LNA microRNA array 7 th generation which contains capture probes targeting all miRs for human listed in miRBASE 18.0. Hybridization was performed using a Tecan HA4800 hybridization station. Slides were then scanned using Agilent G2565BA Microarray Scanner system and image analysis was carried out using ImaGene9 microRNA Array analysis software. The quantified signals were background corrected (Normexp with offset value10) and normalized using the global Lowess (Locally Weighted Scatterplot Smoothing) regression algorithm [ 28 ] . For each comparison the fold change is listed as log2 transformed values. The fold change is calculated as 2^logFC. All calculations have been done with R/ Bioconductor software using mainly the limma package [ 29 ] . All microarray data are deposited in the Gene Expression Omnibus (GEO data base accession No: GSE67016).
Reverse transcription (RT) and quantitative real-time PCR (q-PCR) analyses
For all the RT and q-PCR experiments, total RNA was isolated from each sample using miRNeasy Mini Kit (Qiagen, Valencia, CA) according to manufacturer's manual and quantitated using NanoDrop1000 spectrometry (Thermo Scientific, Wilmington, DE). Equal amounts (1μg) of total RNA were reverse transcribed using Oligo dt primer and AMV reverse transcriptase (Reverse Transcription System, Promega, Madison, WI). 10 ng of total RNA per 15 μl reaction was reverse transcribed using TaqMan miR reverse transcription kit with specific miR primers (Applied Biosystems, Foster City, CA). Q-PCR was performed in triplicate with specific (Survivin, CUG-BP1, HuR, miR-214-3p, U6 and GAPDH) TaqMan primers and probes (Applied Biosystems, Foster City, CA). Two μl cDNA were used in total 20 μl volume per reaction. Reactions were run on a STEP-ONE Plus Real-Time PCR System (Applied Biosystems, Foster City, CA) and cycling conditions were as follows: 2 min at 50°C, 10 min at 95°C, followed by 40 cycles of 15 s at 95°C and 1 min at 60°C. The threshold limit was set so that it intersected all the samples during the log-liner phase of amplification. The levels of GAPDH were used to normalize levels of survivin, CUG-BP1, and HuR in q-PCR samples. For miR experiments, normalization was accomplished using small nuclear RNA U6. mRNA stability mRNA stability assays were performed as previously reported [ 30 ] . Twenty-four hours following transfection as described above, medium containing Actinomycin D (SigmaAldrich, St. Louis, MO) at a final concentration of 0.2μM was added for specified time points. Total RNA was isolated from each sample and qRT-PCR was performed in triplicate as described above.
Biotin-labeled pull-down assays
Biotinylated miR-214-3p (Dharmacon, Lafayette, CO) pull-down assay with target mRNAs was performed as described earlier [ 31 -32 ] . Briefly, 1 × 10 6 TE7 cells were seeded in 10 cm plate in duplicate a day before transfection. Next day, control miR or 3' biotin-labeled miR-214-3p (5'ACAGCAGGCACAGACAGGCAGU 3'Bi) was transfected at a final concentration of 50 nM. After 48 hours, whole cell lysates were harvested. Simultaneously, Streptavidin-Dyna beads (Dyna beads M-280 Streptavidin, #11205D, Invitrogen, 50 μl each sample) were coated with 10 μl per sample yeast tRNA (stock 10 mg/ml Ambion, Austin, TX) and incubated with rotation at 4°C for 2 hrs. Then beads were washed with 500 μl lysis buffer and resuspended in 50 μl lysis buffer. Sample lysates were mixed with pre-coated beads (50 μl per sample) and incubated overnight at 4°C on a rotator. Beads were then pellet down next day to remove unbound materials at 4°C for 1 minute, 5K rpm and washed five times with 500 μl ice cold lysis buffer. To isolate the RNA, 750 μl of TRIzol (Invitrogen, Carlsbad, CA) and 250 μl nuclease free water was added to both input and pulldown samples. Tubes were mixed well and kept in −20°C for 2 hrs. RNA was then precipitated using standard chloroform-isopropanol method and then subjected to q-PCR as explained above. 
Luciferase Reporter Assay
Luciferase reporter constructs were prepared as previously described [ 33 ] . For survivin (Variant 1 NM_001168.2), individual luciferase reporter constructs were generated that contained either the CR, full-length 3' UTR, or one of 3 separate 3'UTR fragments. For CUG-BP1 (Variant 5 NM_ 001172640), the constructs contained either one of 2 CR fragments or one of 3 separate 3' UTR fragments. The inserts were amplified by PCR and individual fragments were subcloned into a NheI and SalI or SacI and Xba1 (New England Bio Labs, Ipswich, MA) digested pmirGLO Dual-Luciferase miRNA target expression vector (Promega, Madison, WI). The constructs containing mutations at the seed sequence binding region of potential binding sites were generated using site directed mutagenesis kit (Agilent Technologies, Santa Clara, CA). All primer sequences used to create these constructs are listed in Tables 2 and 3 . Restriction enzyme digestion and DNA sequencing confirmed the orientation and sequence of the constructs. For luciferase activity assay, 1 × 10 5 TE7 cells/well were plated onto 12-well cell culture plates and co-transfected as described above with luciferase reporter constructs (10ng) and pre-miR-214-3p (50 nM) for 36 hours. Luciferase activity was measured using Dual Luciferase Reporter Assay kit (Promega, Madison, WI), as per manufacturer's protocol. Levels of firefly luciferase activity were normalized to Renilla luciferase activity
Statistical Analysis
Results are expressed as the means ± S.D from three independent experiments with minimum three replicates for each set of experiment. Data derived from multiple determinations were subjected to two-tailed Student's t test and p values < 0.05 were considered statistically significant.
Figure 0001
Figure 0002 Table 1 Fold changes in miRs that are (a) most down-regulated and that are (b) most upregulated in both esophageal cancer cell lines TE7 and TE10 compared to hESO cells. Table 2 Primer sequences used to generate survivin mRNA luciferase reporter constructs for miR-214-3p binding studies. Table 3 Primer sequences used to generate CUG-BP1 mRNA luciferase reporter constructs for miR-214-3p binding studies. 
